Stephen Parodi, MD, describes epidemiologist’s role as ‘dynamic and exciting’
Stephen Parodi, MD, shared his insights on the field of epidemiology and what makes it personally fulfilling for him in U.S. News & World Report.
Stephen Parodi, MD, says reinstituting interventions needed to reduce COVID-19 spread in California
Citing record numbers of COVID-19 cases in California’s hospital system – including 800 patients hospitalized at Kaiser Permanente medical centers in California – Stephen Parodi, MD, told CNN International that it’s time to reinstate some of the coronavirus safety measures that had been lifted in recent weeks.
Stephen Parodi, MD, discusses disparate COVID-19 interventions across the U.S. with Wall Street Journal
Stephen Parodi, MD, executive vice president of The Permanente Federation and national infectious disease leader at Kaiser Permanente, recently discussed the effects of disparate approaches to COVID-19 interventions across the United States with The Wall Street Journal.
Stephen Parodi, MD, tells FierceHealthcare that multipronged strategy is needed to suppress coronavirus
Stephen Parodi, MD, national infectious disease leader for Kaiser Permanente, commented in Fierce Healthcare on Kaiser Permanente’s multipronged COVID-19 suppression strategy, which was outlined in a NEJM Catalyst article earlier this week. That strategy includes 8 key capabilities health systems need to consider as the country reopens.
Kaiser Permanente leaders describe capabilities to suppress COVID-19 in NEJM Catalyst
In an article published this week in NEJM Catalyst, Kaiser Permanente physicians and leaders acknowledge the conundrum of reopening the country for business while preventing successive waves of coronavirus infection, and describe the next strategic phase in the battle against the COVID-19 pandemic: disease suppression.
Berkeley coronavirus testing lab highlighted by Stephen Parodi, MD, in Voice of America video
Stephen Parodi, MD, an associate executive director of The Permanente Medical Group in Northern California, told Voice of America that Kaiser Permanente is working with “light speed” to build a new 7,000-square-foot testing lab in Berkeley.
Initial COVID-19 drug trials ‘give us hope,’ Stephen Parodi, MD, tells CBSN
Stephen Parodi, MD, associate executive director of The Permanente Medical Group and national infectious disease leader for Kaiser Permanente, spoke with CBSN recently about why trials with remdesivir and other drugs matter. CBSN is the CBS News 24/7 digital streaming service.
Tweetcap: AMA, Permanente Federation host chat on safely reopening country during COVID-19 pandemic
On Thursday, the American Medical Association (AMA) and The Permanente Federation co-hosted a tweet chat, "Clinical Perspectives on Safely Reopening America," which generated an online conversation centered on a path for safely steering Americans through the COVID-19 pandemic and toward a return to normalcy.
Pulse oximeter use to detect COVID-19 can’t replace a doctor’s visit
Many patients with severe cases of COVID-19 have extremely low levels of oxygen in the blood. That may be one reason why interest in pulse oximeters — medical devices that measure the saturation of oxygen in red blood cells — has increased recently.
New Kaiser Permanente study provides information on coronavirus planning for health systems
A new Kaiser Permanente study of COVID-19 patients published today as a research letter in the Journal of the American Medical Association (JAMA) provides estimates for the percentage of test-positive patients requiring hospitalization and admission to the ICU.